Actively hiring
Medical AI
Drug Discovery
Follow
Overview
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$284.1M
2 rounds on record
Latest round
$142M
Venture round · Jul 2024 · 2 yr ago
Team
501-1000
employees, estimated range
Backers
1
Foresite Capital
The money's age
Long since its last round
26 months since the last round · not hiring
Momentum
0/100
no fresh signals
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Jul 2024 | $142M | — | SEC Form D |
| Venture round | Jul 2024 | $142M | — | SEC Form D |
Registers and programsofficial lists and records that name the company
| Legal entity | NGM Bio Holdings, Inc. | sec |
Founders and leadersfrom filings, registers and the company's site
Kara CalhounExecutive OfficerSEC Form D
Hsiao LieuExecutive OfficerSEC Form D
David WoodhouseExecutive Officer, DirectorSEC Form D
Daniel KaplanExecutive OfficerSEC Form D
Valerie PierceExecutive OfficerSEC Form D
Jean-Frederic ViretExecutive OfficerSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs
Similar startupsby what they do, their industry and backers

Drug discovery at the resolution of biology. Using the power of the transcriptome to discover revolutionary medicines.

Build better molecules with frontier AI models. With AI, we help every scientist reshape biology.

Abbott develops life-changing medical devices for cardiovascular conditions.

At Prellis Biologics, we harness AI and immune diversity to advance next-gen medicines. Discover our EXIS™ platform and bioprinting…

Developing transformative medicines for neurological and mental health disorders.

Kriya is building durable medicines designed to replace chronic re-treatment with a single administration—therapeutic medicines that can…
People

Kara Calhoun
Executive Officer

Hsiao Lieu
Executive Officer

David Woodhouse
Executive Officer, Director

Daniel Kaplan
Executive Officer

Valerie Pierce
Executive Officer

Jean-Frederic Viret
Executive Officer

Diana Bockus
Executive Officer, Director

Roger Perlmutter
Director

William Rieflin
Director

Shelly Guyer
Director

David Goeddel
Director

Peter Svennilson
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
South San Francisco
United States
HQ
500-1000 est. staff
611 Gateway Blvd., Suite 540, South San Francisco, CA 94080

Foresite Capital